title: In regard to Boccia et al.: assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP) (INT J RADIAT ONCOL BIOL PHYS 2004;60:302-309).
authors.forename: Ayse
authors.initials: A
authors.lastname: Hicsonmez
authors.forename: Meltem Nalca
authors.initials: MN
authors.lastname: Andrieu
authors.forename: Serap
authors.initials: S
authors.lastname: Akyurek
authors.forename: Metehan
authors.initials: M
authors.lastname: Karaca
authors.forename: Aysun
authors.initials: A
authors.lastname: Cagar
authors.forename: Fuat
authors.initials: F
authors.lastname: Ciner
authors.forename: Cengiz
authors.initials: C
authors.lastname: Kurtman
mesh_terms: D004999:Amifostine / Q000009:adverse effects*; D001768:Blister / Q000139:chemically induced; D004892:Erythema Multiforme / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011837:Radiation-Protective Agents / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000209:etiology*
chemical_list: D011837:Radiation-Protective Agents; D004999:Amifostine